Assessment of Neonatal Intensive Care Unit Practices and Preterm Newborn Gut Microbiota and 2-Year Neurodevelopmental

Jean-Christophe Rozé1, Pierre-Yves Ancel2,3, Laetitia Marchand-Martin2

  • 1Neonatal Department, INSERM-CHU Clinical Investigation Center 1413, et UMR- INRA 1280, Physiologie des Adaptations Nutritionnelles, Nantes University Hospital, Nantes, France.

JAMA Network Open
|September 23, 2020
PubMed

Insights

Neonatal intensive care unit (NICU) practices influence gut microbiota in very preterm infants. Specific microbiota compositions are linked to adverse long-term neurodevelopmental outcomes at two years.

Area of Science:

  • Neonatology
  • Microbiology
  • Developmental Pediatrics

Background:

  • Gut microbiota in very preterm newborns is highly variable and often dysbiotic.
  • While short-term health associations are known, the link between gut microbiota and long-term infant outcomes is unclear.

Purpose of the Study:

  • To examine associations between neonatal intensive care unit (NICU) practices, gut microbiota composition, and infant outcomes at two years of age.

Main Methods:

  • Prospective observational cohort study (EPIFLORE) of preterm infants (<32 weeks gestational age).
  • Stool samples analyzed via 16S rRNA gene sequencing during the fourth week after birth.
  • Two-year outcomes assessed for death or neurodevelopmental delay using the Ages and Stages Questionnaire.

Main Results:

  • Gut microbiota clustered into distinct groups, with some associated with lower gestational age.
  • NICU practices like ventilation, sedation, and enteral nutrition volume significantly impacted microbiota composition.
  • Specific microbiota clusters (Enterococcus, Staphylococcus-dominant) were associated with increased risk of nonoptimal two-year outcomes.

Conclusions:

  • Gut microbiota composition in very preterm infants at four weeks is associated with NICU care strategies.
  • Microbiota profiles correlate with neurodevelopmental outcomes at two years.
  • Gut microbiota may serve as a noninvasive biomarker for infant immaturity and long-term prognosis.
Abstract